Filament Health Corp Stock Beta

FLHLF Stock  USD 0.03  0.01  14.29%   
Filament Health Corp fundamentals help investors to digest information that contributes to Filament Health's financial success or failures. It also enables traders to predict the movement of Filament OTC Stock. The fundamental analysis module provides a way to measure Filament Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Filament Health otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Filament Health Corp OTC Stock Beta Analysis

Filament Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Filament Health Corp has a Beta of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The beta for all United States stocks is 100.0% lower than that of the firm.

Filament Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Filament Health's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Filament Health could also be used in its relative valuation, which is a method of valuing Filament Health by comparing valuation metrics of similar companies.
Filament Health is currently under evaluation in beta category among its peers.

Filament Fundamentals

About Filament Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Filament Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Filament Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Filament Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Filament OTC Stock

Filament Health financial ratios help investors to determine whether Filament OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Filament with respect to the benefits of owning Filament Health security.